effort
develop
broadli
protect
vaccin
highli
pathogen
avian
influenza
hpai
viru
focus
highli
conserv
influenza
gene
product
viral
nucleoprotein
np
ion
channel
matrix
protein
highli
conserv
among
differ
strain
variou
influenza
subtyp
investig
rel
efficaci
np
compar
ha
protect
hpai
viru
mice
previou
studi
shown
vaccin
np
recombin
dna
andor
adenoviru
vector
adjuv
confer
protect
lethal
challeng
absenc
ha
howev
find
protect
efficaci
np
diminish
virul
dose
challeng
viru
increas
explor
question
model
relev
human
diseas
ferret
immun
vaccin
encod
np
ha
ha
vaccin
confer
protect
stringent
viru
challeng
therefor
genebas
vaccin
np
may
provid
moder
level
protect
low
challeng
dose
insuffici
confer
protect
immun
high
challeng
dose
ferret
immunogen
may
requir
combinatori
vaccin
ha
confer
protect
even
high
dose
lethal
viral
challeng
openaccess
articl
distribut
term
creativ
common
public
domain
declar
stipul
place
public
domain
work
may
freeli
reproduc
distribut
transmit
modifi
built
upon
otherwis
use
anyon
law
purpos
sinc
highli
pathogen
avian
influenza
viral
strain
caus
sever
diseas
poultri
wild
bird
although
spread
wide
human
sporad
infect
seen
throughout
countri
eastern
asia
middl
east
africa
date
confirm
human
case
death
mortal
rate
report
world
health
organ
http
wwwwhointcsrdiseas
almost
case
infect
physic
contact
infect
bird
primari
mode
transmiss
may
animaltohuman
concern
remain
viru
may
evolv
strain
capabl
humantohuman
transmiss
vaccin
offer
practic
effect
measur
control
spread
highli
pathogen
viru
threat
pose
emerg
strain
influenza
unpredict
vari
among
countri
evidenc
recent
swine
origin
pandem
highlight
need
improv
vaccin
confer
broad
protect
multipl
viral
strain
variou
influenza
subtyp
hemagglutinin
ha
surfac
protein
convent
primari
target
strainspecif
influenza
dna
vaccin
conserv
viral
epitop
potenti
induc
immun
divers
influenza
strain
two
highli
conserv
influenza
viral
protein
np
wide
target
possibl
broadli
protect
vaccin
candid
main
function
nucleoprotein
encapsid
viral
genom
form
ribonucleoprotein
particl
transcript
packag
np
also
interact
viral
protein
cellular
protein
importin
factin
viral
transcript
control
nuclear
transport
control
respons
protein
transloc
express
high
densiti
plasma
membran
infect
cell
tetram
form
ion
channel
protein
also
target
antivir
drug
amantidin
rimantadin
control
viral
replic
use
influenza
prophylaxi
treatment
mice
vaccin
np
strain
induc
humor
cellular
immun
respons
protect
lethal
challeng
howev
mous
model
ideal
evalu
infect
vaccin
due
differ
ha
receptor
specif
distribut
influenza
pathogen
well
clinic
symptomatolog
infect
ferret
show
greater
similar
human
infect
term
anatom
distribut
diseas
outbr
ferret
exhibit
sever
lethargi
fever
weight
loss
transient
lymphopenia
well
viral
replic
upper
lower
respiratori
tract
brain
multipl
system
organ
infect
variou
strain
viru
thu
model
wide
consid
reflect
human
influenza
infect
continu
evalu
protect
efficaci
np
mous
model
extend
investig
ferret
model
studi
previou
studi
investig
protect
efficaci
conserv
epitop
lethal
influenza
challeng
mice
ferret
dna
vaccin
np
combin
formul
vaxfectin
shown
protect
mice
heterosubtyp
challeng
virus
vaxfectinformul
dna
vaccin
encod
protect
mice
high
challeng
dose
viru
ferret
delay
time
ill
death
howev
tripl
prime
rad
boost
regimen
np
combin
shown
protect
ferret
viru
albeit
rel
low
challeng
dose
studi
evalu
protect
immun
induc
np
alon
combin
ha
tripl
prime
rad
boost
regimen
high
dose
lethal
challeng
initi
test
abil
dna
immun
ha
alon
np
alon
hanp
protect
high
dose
lethal
challeng
mice
assess
abil
np
alon
combin
protect
ferret
high
challeng
dose
lethal
viru
deliv
tripl
dna
prime
boost
regimen
compar
group
ferret
immun
ha
alon
combin
plasmid
encod
ha
genbank
np
genbank
genbank
genbank
synthes
use
humanpref
codon
construct
cmvr
backbon
geneart
regensburg
germani
previous
describ
gene
express
confirm
use
invitrogen
carlsbad
ca
transfect
cell
western
blot
analysi
three
separ
replicationdefect
rad
serotyp
vector
express
ha
np
gene
produc
previous
describ
briefli
gene
insert
adenovir
vector
system
genvec
gaithersburg
md
base
human
serotyp
contain
delet
region
part
region
render
replicationdefect
vector
use
describ
elsewher
vector
stock
serial
passag
complement
mammalian
cell
gener
hightit
stock
replicationdefect
adenovirus
absenc
replicationcompet
adenoviru
confirm
productreleas
assay
gene
express
american
type
cultur
collect
manassa
va
cell
confirm
western
blot
analysi
prior
anim
immun
plasmid
adenovirus
encod
variou
influenza
viral
gene
test
express
cell
plasmid
encod
ha
protein
np
protein
protein
transfer
cell
use
calcium
phosphatemedi
profectionh
mammalian
transfect
system
promega
madison
wi
adenovirus
encod
ha
np
transfect
cell
hour
follow
chang
media
cell
lysat
collect
hour
posttransfect
subject
western
blot
analysi
mous
monoclon
antibodi
ha
np
np
ferret
antiserum
rais
specif
band
predict
size
protein
detect
comparison
known
vector
control
highli
virul
viru
isol
human
fatal
case
influenza
use
studi
viru
stock
propag
allanto
caviti
embryon
hen
egg
follow
incub
hour
allanto
fluid
multipl
egg
pool
clarifi
centrifug
divid
aliquot
store
egg
infecti
dose
eid
titer
determin
serial
titrat
virus
egg
calcul
reed
muench
method
lethal
dose
ld
determin
previous
describ
research
hpai
viru
conduct
biosafeti
level
contain
includ
enhanc
requir
us
depart
agricultur
select
agent
program
anim
research
conduct
guidanc
center
diseas
control
prevent
institut
anim
care
use
committe
anim
facil
accredit
associ
assess
accredit
laboratori
anim
care
intern
femal
balbc
mice
week
old
jackson
lab
bar
harbor
immun
previous
describ
ha
np
briefli
mice
anim
group
ha
alon
hanp
anim
np
alon
vector
control
immun
three
time
total
mg
plasmid
dna
ml
pb
ph
intramuscularli
week
singl
ha
np
plasmid
group
group
receiv
mg
dna
plasmid
mg
control
vector
filler
dna
total
mg
plasmid
combin
group
hanp
mg
plasmid
plu
mg
control
vector
use
plasmid
combin
group
mg
plasmid
dna
use
total
dna
remain
mg
serum
collect
day
last
dna
vaccin
viral
challeng
experi
perform
week
last
immun
challeng
anim
expos
co
anesthesia
intranas
viral
inoculum
ld
viru
bodi
weight
surviv
monitor
day
viral
challeng
experi
conduct
center
diseas
control
prevent
atlanta
ga
previous
describ
male
fitch
ferret
month
age
tripl
f
farm
sayr
pa
serolog
neg
hemagglutinin
inhibit
hai
assay
current
circul
influenza
virus
use
studi
ha
np
gene
number
anim
use
studi
follow
anim
group
np
alon
b
anim
neg
control
group
c
anoth
experi
anim
three
group
ha
alon
vector
control
ferret
immun
three
time
total
mg
plasmid
dna
ml
pb
ph
intramuscularli
quadricep
muscl
week
singl
compon
plasmid
group
anim
receiv
mg
dna
plasmid
mg
control
vector
filler
dna
total
mg
plasmid
combin
group
eg
mg
np
plasmid
mg
control
vector
use
total
mg
plasmid
combin
group
mg
three
plasmid
dna
use
total
dna
remain
total
mg
week
ferret
immun
intramuscularli
particl
recombin
adenovirus
express
ha
np
differ
combin
similar
dna
immun
combin
serum
collect
day
last
vaccin
dna
adenoviru
immun
conduct
bioqual
inc
rockvil
md
nine
ten
week
adenoviru
boost
immun
ferret
challeng
viru
ident
np
amino
acid
sequenc
immun
strain
center
diseas
control
prevent
atlanta
ga
previous
describ
briefli
day
prior
infect
baselin
serum
bodi
temperatur
weight
measur
ferret
obtain
ferret
anesthet
intramuscular
inject
ketamin
hydrochlorid
mgkg
xylazin
mgkg
atropin
mgkg
cocktail
inocul
intranas
eid
viru
ml
pb
ferret
monitor
chang
bodi
temperatur
weight
presenc
follow
clinic
symptom
sneez
lethargi
anorexia
nasal
ocular
discharg
dyspnea
diarrhea
neurolog
dysfunct
bodi
temperatur
measur
use
implant
subcutan
temperatur
transpond
biomed
data
system
inc
seaford
de
viral
titer
measur
nasal
wash
collect
day
postinfect
anesthet
ferret
previous
describ
nasal
wash
immedi
frozen
dri
ice
store
process
viral
titer
nasal
wash
determin
egg
describ
ferret
lost
bodi
weight
exhibit
neurolog
dysfunct
euthan
submit
postmortem
examin
bodi
weight
clinic
symptom
sign
morbid
surviv
monitor
day
statist
signific
differ
surviv
group
determin
use
logrank
test
elisa
assay
use
studi
previous
describ
detail
briefli
elisa
plate
coat
antigen
mlwell
follow
endpoint
titer
determin
linear
regress
analysi
absorb
valu
od
previous
describ
r
obtain
seri
threefold
dilut
cutoff
valu
set
microneutr
assay
detect
humor
neutral
respons
influenza
perform
previous
describ
mice
twofold
dilut
heatinactiv
sera
test
presenc
antibodi
neutral
infect
tissu
cultur
infecti
dose
virus
mdck
cell
monolay
use
two
well
per
dilut
plate
describ
day
incub
cell
fix
elisa
perform
detect
presenc
viral
nucleoprotein
np
determin
neutral
activ
ferret
neutral
antibodi
activ
analyz
mn
assay
base
method
global
influenza
program
sera
treat
receptordestroy
enzym
dilut
one
part
serum
three
part
enzym
incub
overnight
water
bath
heatinactiv
describ
hai
assay
viru
strain
use
mn
assay
lowpathogen
reassort
obtain
ruben
doni
cdc
influenza
branch
hemagglutin
inhibit
hai
assay
ferret
sera
hai
assay
perform
use
four
hemagglutinin
unit
viru
hors
rbc
previous
describ
ferret
sera
treat
receptordestroy
enzym
dilut
one
part
serum
three
part
enzym
incub
overnight
water
bath
enzym
inactiv
min
incub
follow
addit
six
part
pb
final
dilut
viru
strain
use
hai
assay
lowpathogen
reassort
obtain
ruben
doni
cdc
influenza
branch
atlanta
ga
clade
clade
seed
stock
reassort
strain
obtain
expand
bioqual
embryon
chicken
egg
viru
strain
use
hai
assay
ident
low
pathogen
reassort
list
mn
assay
recombin
lentivir
vector
express
luciferas
report
gene
produc
previous
describ
assay
develop
safer
highli
sensit
altern
hai
mn
assay
appli
highthroughput
format
influenza
vaccin
evalu
briefli
hapseudotyp
lentivir
vector
encod
luciferas
first
titrat
serial
dilut
concentr
viru
give
maximum
activ
incub
indic
amount
mous
antiserum
ad
cell
plate
wash
replac
fresh
media
hour
later
luciferas
activ
measur
hour
previous
describ
use
mammalian
cell
lysi
buffer
luciferas
assay
reagent
promega
madison
wi
accord
manufactur
protocol
linear
regress
util
determin
endpoint
titer
antibodi
differ
antigen
addit
surviv
differ
anim
group
test
logrank
test
use
graphpad
prism
softwar
san
diego
ca
endpoint
antibodi
titer
log
scale
differ
group
compar
oneway
analysi
varianc
anova
signific
alpha
proceed
look
pairwis
comparison
use
ttest
four
group
mice
studi
pvalu
pairwis
test
compar
bonferroniadjus
threshold
comparison
made
set
group
relev
immunogen
three
group
ferret
studi
use
instead
fisher
least
signific
differ
method
maintain
threshold
alpha
pairwis
test
follow
signific
anova
prior
anim
immun
express
specif
influenza
viral
gene
confirm
cell
figur
combinatori
dna
vaccin
ha
np
follow
viral
challeng
mice
evalu
differ
dna
immunogen
ha
alon
ha
np
ha
np
np
abil
elicit
protect
immun
use
mous
challeng
model
studi
cohort
consist
femal
balbc
mice
ha
alon
hanp
group
anim
np
alon
vector
control
group
serum
collect
day
last
dna
vaccin
endpoint
elisa
titer
evalu
dna
immun
figur
hacontain
group
show
increas
ha
elisa
titer
compar
control
cohort
figur
left
panel
might
expect
level
appear
decreas
number
gene
product
dna
vaccin
although
signific
differ
observ
amongst
hacontain
group
analyz
antibodi
respons
np
protein
figur
middl
panel
result
anova
borderlin
pvalu
pairwis
comparison
ha
alon
hanp
group
similar
p
bonferroniadjust
threshold
howev
analyz
antibodi
respons
protein
dna
vaccin
combin
ha
np
elicit
signific
humor
respons
compar
control
figur
right
panel
result
suggest
immunogen
although
immun
alon
includ
studi
defin
neutral
antibodi
respons
mous
sera
pool
group
pseudotyp
neutral
microneutr
assay
perform
analys
reveal
neutral
activ
ha
group
lower
titer
anim
immun
hanp
lowest
respons
vaccin
tabl
howev
minim
neutral
evid
nponli
immun
anim
hai
assay
perform
mous
sera
determin
efficaci
altern
dna
immun
mice
challeng
hpai
viru
mice
challeng
intranas
ld
viru
provid
stringent
evalu
protect
efficaci
anim
control
np
alon
group
die
within
day
viral
challeng
wherea
anim
immun
ha
alon
hanp
show
surviv
rate
respect
figur
surviv
rate
statist
significantli
differ
expect
ha
alon
group
show
least
amount
bodi
weight
loss
group
hanp
show
similar
weight
loss
pattern
figur
contrast
control
np
group
show
immun
protect
demonstr
sever
weight
loss
figur
find
suggest
np
dna
immun
confer
protect
viral
challeng
dose
use
determin
compar
efficaci
altern
genebas
vaccin
ferret
immun
ferret
gene
product
differ
combin
tripl
dna
inmmun
experi
anim
receiv
recombin
adenoviru
serotyp
boost
order
increas
immunogen
dna
prime
ferret
immun
ha
alon
n
n
np
alon
n
n
alon
n
empti
vector
control
n
elisa
titer
ha
np
determin
dna
immun
figur
white
bar
boost
figur
black
bar
expect
dna
immun
ha
alon
group
elicit
immun
group
compar
control
well
group
contain
relev
immunogen
anova
test
signific
respons
ha
np
ha
signific
pair
group
note
graph
pvalu
less
bonferroni
correct
consid
signific
pairwis
comparison
singl
asterisk
repres
pvalu
indic
indic
hacontain
group
show
signific
antibodi
respons
ha
compar
control
differ
significantli
among
differ
npimmun
group
border
statist
signific
anova
p
comparison
hanp
ha
group
p
adjust
multipl
comparison
group
elicit
signific
humor
respons
protein
compar
control
signific
antiha
immun
increas
ha
boost
figur
left
panel
compar
control
group
elicit
similar
antiha
elisa
antibodi
well
signific
antinp
humor
respons
p
respons
rad
boost
figur
middl
right
panel
compar
control
np
immun
group
signific
antinp
humor
respons
observ
rad
boost
figur
middl
panel
compar
control
signific
humor
respons
detect
anim
immun
postrad
boost
p
alon
group
figur
right
panel
rel
control
humor
respons
detect
case
except
immun
combin
np
abil
ha
antibodi
immun
ferret
neutral
viru
analyz
three
assay
pseudotyp
lentivir
vector
neutral
assay
ha
inhibit
assay
microneutr
assay
tabl
ferret
hacontain
group
show
substanti
neutral
antibodi
titer
respons
np
group
show
neutral
assay
least
nine
week
boost
ferret
challeng
high
dose
viru
group
lack
ha
includ
np
alon
alon
develop
sever
diseas
manifest
signific
weight
loss
neurolog
dysfunct
less
seven
day
viral
challeng
similar
clinic
symptom
observ
control
group
figur
left
panel
anim
euthan
due
sever
symptom
bodi
weight
loss
among
group
similar
figur
left
panel
contrast
ha
group
complet
protect
lethal
high
dose
influenza
viru
challeng
compar
surviv
empti
vector
immun
control
figur
right
panel
three
anim
show
mild
clinic
sign
slight
temperatur
elev
weight
loss
three
day
viral
challeng
symptom
disappear
within
two
day
bodi
weight
two
group
remain
steadi
postvir
challeng
haimmun
ferret
figur
right
panel
contrast
control
viral
titer
nasal
wash
confirm
antivir
effect
habut
npcontain
vaccin
data
shown
control
anim
show
peak
viral
titer
day
subsequ
die
day
ha
group
show
moder
viral
titer
day
follow
quick
clearanc
viral
titer
detect
day
day
data
shown
surviv
bodi
weight
viral
titer
indistinguish
ha
group
viral
challeng
suggest
np
contribut
immun
protect
ferret
ha
immun
respons
alon
necessari
suffici
protect
ferret
lethal
effect
infect
challeng
condit
highli
conserv
viral
gene
np
becom
focu
develop
broad
crossprotect
univers
influenza
vaccin
mice
sever
studi
shown
genebas
immun
np
induc
strong
humor
cellular
respons
protect
lethal
challeng
studi
mice
immun
dna
vaccin
encod
ha
alon
np
alon
hanp
hacontain
group
group
gener
signific
antibodi
respons
ha
protein
respect
howev
hanp
group
elicit
respons
np
protein
margin
signific
best
moreov
hacontain
group
protect
lethal
challeng
surviv
rate
least
immun
np
alon
protect
mice
lethal
challeng
figur
neutral
determin
lentivir
inhibit
assay
hemagglutinin
inhibit
assay
microneutr
assay
sera
indic
mous
ferret
immun
indic
viral
antigen
dna
alon
viral
challeng
evalu
pseudotyp
lentivir
inhibit
hemagglutinin
inhibit
hai
microneutr
assay
mn
ud
repres
serum
sampl
undetect
neutral
activ
even
lowest
dilut
na
repres
sampl
avail
therefor
assess
mice
ferret
hacontain
group
stimul
strong
humor
respons
previou
studi
np
immun
yield
mix
result
like
depend
mode
genebas
vaccin
dose
challeng
viru
though
first
studi
use
np
dna
immun
confer
protect
lethal
influenza
challeng
retrospect
result
may
seen
rel
low
challeng
dose
recent
studi
challeng
dose
overcam
np
dna
vaccin
protect
similar
amount
use
np
immun
dna
rad
deriv
strain
result
protect
mice
challeng
heterolog
viru
strain
protect
seen
virul
strain
appear
protect
afford
immun
np
mice
diminish
markedli
dose
virul
challeng
viru
increas
howev
dna
vaccin
np
combin
shown
protect
mice
vaxfectin
formul
radboost
regimen
investig
alon
mice
previou
studi
shown
vaccin
alon
capabl
protect
mice
heterolog
strain
influenza
viru
challeng
includ
despit
show
neutral
antibodi
respons
mice
immun
fulli
protect
lethal
challeng
lalor
et
al
show
similar
result
vaxfectinformul
dna
vaccin
encod
consensu
gene
protect
mice
challeng
despit
low
hai
respons
suggest
use
mechan
protect
cytotox
tlymphocyt
although
assess
studi
previou
studi
immun
also
suggest
cellular
immun
may
contribut
protect
model
mous
model
use
immunogen
studi
murin
diseas
pathogen
human
infect
ideal
infect
studi
differ
may
due
speci
chang
ha
receptor
specif
distribut
well
differenti
immunopathogen
contrast
gener
accept
ferret
exhibit
patholog
similar
human
infect
includ
sever
lethargi
fever
weight
loss
transient
lymphopenia
viral
replic
upperlow
respiratori
tract
multipl
system
organ
furthermor
human
isol
influenza
viru
shown
attach
infect
ferret
airway
indic
human
ferret
share
similar
ha
receptor
specif
ferret
immun
ha
alon
np
alon
alon
control
use
genebas
vaccin
deliv
vector
sinc
establish
statist
differ
control
group
group
immun
np
ha
group
show
surviv
right
panel
wherea
vector
control
group
show
surviv
viral
challeng
statist
signific
differ
ha
group
p
signific
differ
group
control
p
logrank
test
b
bodi
weight
ferret
also
monitor
total
bodi
weight
surviv
anim
group
compar
respect
initi
bodi
weight
left
panel
ferret
immun
ha
group
show
weight
loss
control
group
ferret
show
rapid
weight
loss
right
panel
surviv
initi
anim
number
group
last
day
bodi
weight
data
collect
indic
next
curv
label
surviv
percentag
group
analyz
statist
logrank
test
antigen
bar
repres
group
mean
endpoint
titer
total
igg
igm
determin
duplic
seri
dilut
elisa
assay
error
bar
indic
standard
deviat
anova
test
signific
respons
ha
first
time
point
three
antigen
boost
ha
signific
pair
group
note
graph
pvalu
less
indic
repres
pvalu
indic
indic
expect
ha
alon
group
elicit
signific
antiha
immun
increas
ha
boost
left
panel
compar
control
group
elicit
similar
antiha
elisa
antibodi
well
signific
antinp
humor
respons
p
respons
rad
boost
middl
right
panel
b
sera
np
vector
control
collect
day
third
dna
immun
white
bar
sera
anim
also
collect
day
recombin
adenoviru
boost
solid
bar
anova
test
signific
antigen
first
time
point
np
boost
np
signific
pair
group
note
graph
pvalu
less
indic
repres
pvalu
indic
indic
np
immun
group
signific
antinp
humor
respons
observ
rad
boost
middl
panel
signific
humor
respons
detect
anim
immun
postrad
boost
p
alon
group
right
panel
assay
avail
measur
cellular
respons
ha
np
ferret
efficaci
immunogen
evalu
base
measur
neutral
antibodi
titer
microneutr
hainhibit
assay
ha
np
present
signific
humor
respons
stimul
protein
howev
antibodi
stimul
combin
np
suggest
possibl
immun
synergi
two
gene
product
similar
adjuv
effect
np
respons
recent
report
mice
group
challeng
lethal
strain
hpai
vaccin
contain
ha
confer
protect
np
group
surviv
lalor
et
al
show
protect
mice
formul
vaxfectin
vaccin
dose
time
greater
use
studi
howev
ferret
absenc
ha
combin
result
delay
ill
death
price
et
al
show
protect
ferret
tripleprim
rad
boost
regimen
similar
one
use
differ
result
may
due
higher
dose
dna
primari
immun
tenfold
greater
present
studi
well
much
lower
viral
challeng
dose
compar
studi
howev
due
differ
experiment
paramet
immun
regimen
assay
standard
direct
comparison
np
immun
respons
studi
difficult
addit
differ
vaccin
may
alter
variou
antibodi
cellular
immun
respons
may
affect
protect
immun
variou
anim
model
nonetheless
evid
suggest
np
may
provid
moder
level
protect
low
dose
viral
challeng
ferret
insuffici
high
challeng
dose
hpai
hand
ha
elicit
effect
immun
protect
even
high
hpai
viral
challeng
dose
although
vaccin
encod
np
alon
requir
protect
could
potenti
augment
haencod
vaccin
particularli
mismatch
vaccin
viral
ha
protein
studi
mice
shown
antibodi
may
help
reduc
viral
replic
studi
ferret
shown
associ
reduct
viral
recoveri
howev
base
challeng
result
ferret
ha
dna
immun
superior
np
dna
immun
term
protect
highli
conserv
viral
gene
may
requir
combinatori
vaccin
ha
suitabl
candid
univers
influenza
vaccin
